[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK573274A - - Google Patents

Info

Publication number
DK573274A
DK573274A DK573274A DK573274A DK573274A DK 573274 A DK573274 A DK 573274A DK 573274 A DK573274 A DK 573274A DK 573274 A DK573274 A DK 573274A DK 573274 A DK573274 A DK 573274A
Authority
DK
Denmark
Application number
DK573274A
Other languages
Danish (da)
Other versions
DK136719B (da
DK136719C (fr
Inventor
R A Archer
Original Assignee
Lilly E And Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly E And Co filed Critical Lilly E And Co
Publication of DK573274A publication Critical patent/DK573274A/da
Publication of DK136719B publication Critical patent/DK136719B/da
Application granted granted Critical
Publication of DK136719C publication Critical patent/DK136719C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DK573274AA 1973-11-05 1974-11-04 Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner. DK136719B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (3)

Publication Number Publication Date
DK573274A true DK573274A (fr) 1975-07-07
DK136719B DK136719B (da) 1977-11-14
DK136719C DK136719C (fr) 1978-04-24

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
DK573274AA DK136719B (da) 1973-11-05 1974-11-04 Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner.

Country Status (26)

Country Link
US (1) US3968125A (fr)
JP (1) JPS6033835B2 (fr)
AR (1) AR202318A1 (fr)
AT (1) AT336012B (fr)
BE (1) BE821716A (fr)
BG (1) BG26387A3 (fr)
CA (1) CA1023753A (fr)
CH (1) CH605894A5 (fr)
CS (1) CS193507B2 (fr)
DD (1) DD116230A5 (fr)
DE (1) DE2451934C2 (fr)
DK (1) DK136719B (fr)
ES (1) ES431674A1 (fr)
FR (1) FR2249664B1 (fr)
GB (1) GB1487637A (fr)
HU (1) HU169193B (fr)
IE (1) IE40023B1 (fr)
IL (1) IL45644A (fr)
NL (1) NL7414439A (fr)
PH (1) PH11788A (fr)
PL (2) PL93908B1 (fr)
RO (1) RO71766A (fr)
SE (1) SE415762B (fr)
SU (1) SU524517A3 (fr)
YU (1) YU36515B (fr)
ZA (1) ZA745751B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (fr) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
EP1554572B1 (fr) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
PT1477186E (pt) * 2002-02-19 2010-02-11 Shionogi & Co Antipruriginosos
CA2608144C (fr) 2005-04-28 2012-11-13 Proteus Biomedical, Inc. Systeme pharma-informatique
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
CN101815697A (zh) * 2007-07-30 2010-08-25 奥特兰兹公司 大麻二酚前药、包括大麻二酚前药的组合物及其使用方法
WO2009099670A2 (fr) * 2008-02-08 2009-08-13 Nektar Therapeutics Al, Corporation Conjugués d'oligomère et de cannabinoïde
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
CA2760945A1 (fr) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Compositions pour liberation dermique comprenant des complexes principe actif-particule de phosphate de calcium et procedes d'utilisation associes
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20200197357A1 (en) 2017-07-20 2020-06-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods of lipophilic drugs
CN111278425B (zh) 2017-09-11 2024-06-11 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于向脑部经鼻给药药物和用于全身作用的组合物和方法
WO2019106652A1 (fr) 2017-11-29 2019-06-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions de cannabinoïdes et méthodes
CA3116194A1 (fr) 2018-11-04 2020-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions contenant des cannabinoides administrables par voie orale et procedes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
AU7321274A (en) 1976-03-18
YU265874A (en) 1982-02-25
CA1023753A (fr) 1978-01-03
SE7413833L (fr) 1975-05-06
PL93908B1 (fr) 1977-07-30
JPS6033835B2 (ja) 1985-08-05
IE40023B1 (en) 1979-02-28
HU169193B (fr) 1976-10-28
DK136719B (da) 1977-11-14
CS193507B2 (en) 1979-10-31
DE2451934A1 (de) 1975-05-07
BG26387A3 (bg) 1979-03-15
FR2249664B1 (fr) 1978-03-24
PL95748B1 (pl) 1977-11-30
RO71766A (fr) 1982-12-06
DE2451934C2 (de) 1983-10-06
GB1487637A (en) 1977-10-05
AT336012B (de) 1977-04-12
IL45644A0 (en) 1974-11-29
DD116230A5 (fr) 1975-11-12
IE40023L (en) 1975-05-05
ZA745751B (en) 1976-04-28
BE821716A (fr) 1975-04-30
DK136719C (fr) 1978-04-24
CH605894A5 (fr) 1978-10-13
FR2249664A1 (fr) 1975-05-30
SE415762B (sv) 1980-10-27
US3968125A (en) 1976-07-06
NL7414439A (nl) 1975-05-07
IL45644A (en) 1978-03-10
YU36515B (en) 1984-02-29
SU524517A3 (ru) 1976-08-05
JPS5071678A (fr) 1975-06-13
PH11788A (en) 1978-07-05
AR202318A1 (es) 1975-05-30
ES431674A1 (es) 1976-11-16
ATA886374A (de) 1976-08-15

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AR201231Q (fr)
AU474593B2 (fr)
DK136719C (fr)
AU474838B2 (fr)
AU476714B2 (fr)
AU476696B2 (fr)
AU477823B2 (fr)
AU476873B1 (fr)
AU477824B2 (fr)
AR196382A1 (fr)
AR193950A1 (fr)
AR195948A1 (fr)
AR195311A1 (fr)
AR196123Q (fr)
AR196212Q (fr)
BG20168A1 (fr)
CH561548A5 (fr)
CH559481A5 (fr)
AU479405A (fr)
BG19319A1 (fr)
AU480973A (fr)
AU479562A (fr)
AU479539A (fr)
AU479522A (fr)

Legal Events

Date Code Title Description
PBP Patent lapsed